Skip to content

Prognostic Value of Number of Metastatic Nodes in School-Age Children and Adolescents With Papillary Thyroid Cancer: A Real-Life Multicenter Study.

Jul 2026 · Clinical Nuclear Medicine · Vol 51, pp. 791-797 · 0 citations · 25 references
Medicine

TL;DR

The number of metastatic nodes is a predominant factor associated with persistent disease, and incorporating quantitative assessment of metastatic nodes may improve risk stratification in SACAs with N1b PTC.

Abstract

Background

How metastatic nodal burden influences the prognosis of school-age children and adolescents (SACAs) with papillary thyroid cancer (PTC) remains unclear. We investigated the independent impact of numerical metastatic nodal burden on clinical outcomes in these patients.

Materials And Methods

This multicenter retrospective cohort study included SACAs with PTC aged 18 years and older who had undergone total thyroidectomy and radioiodine therapy across 12 nuclear medicine departments in China. Persistent biochemical and structural diseases were evaluated. The independent role of metastatic nodes in persistent disease was evaluated using Cox proportional hazards regression.

Results

In total, 486 SACAs with PTC were analyzed, of whom 115 had N1a and 371 had N1b. Among SACAs with N1b PTC, a higher number of metastatic lymph nodes, analyzed as a continuous variable, was identified as an independent risk factor for persistent structural disease (HR: 1.06; 95% CI: 1.01-1.11). When analyzed as a categorical variable, patients in the third (16-22 nodes) and fourth (>22 nodes) quartiles of the number of metastatic nodes exhibited an increased hazard of persistent structural disease (HR: 3.35; 95% CI: 1.13-9.97; P=0.029 and HR: 5.52; 95% CI: 1.59-19.13; P=0.007, respectively). ROC analysis identified a cutoff of ≥14 metastatic lymph nodes for predicting persistent structural diseases. However, for SACAs with N1a PTC, analysis of the number of metastatic nodes revealed no association with persistent disease.

Conclusions

The number of metastatic nodes is a predominant factor associated with persistent disease, and incorporating quantitative assessment of metastatic nodes may improve risk stratification in SACAs with N1b PTC.

View source

Similar papers

Open access Jul 2026

Distant lymph node metastasis in head and neck cancer: incidence, predictors, and survival outcomes in a population-based cohort

It is suggested that subclassifying metastatic disease could enhance risk stratification and guide more personalized treatment strategies in a population-based cohort of patients with HNC.

Jian-Lin Yue, Da-Yu Liu, Rui-Jie Sun et al. · 0 citations
Open access Aug 2026

TERT Promoter Variants, Older Age, and Prognosis in Papillary Thyroid Carcinoma.

The findings of this cohort study suggest that the high prevalence of TERT promoter variants in older patients largely explains the association between age and worse prognosis in PTC.

V. R. Marczyk, Sophie Li, Chia C. Wu et al. · 0 citations
Jul 2026

Clinical and molecular prognostic factors in newly diagnosed pediatric T-cell lymphoblastic lymphoma: a prospective, multicenter, single-arm phase 2 clinical trial

Adjusting the risk stratification based on treatment response significantly improved the overall prognosis of T-LBL, and molecular genetic risk factors might contribute to further risk stratification and provide potential therapeutic targets.

Xia Guo, Chao-Ban Wang, Yue-Jia Tang et al. · 0 citations
Open access Aug 2026

Prognostic Value of BMI in Patients with Metastatic Cervical Cancer:A Retrospective Study From Turkey

Higher BMI is associated with poorer overall survival in patients with metastatic cervical cancer and the findings highlight the importance of nutritional assessment and suggest that BMI may serve as a prognostic marker associated with survival outcomes in this population.

Rumeysa Çolak, C. Kapar, S. Tacar et al. · 0 citations
Open access Aug 2026

Predictive Factors of Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer: A Retrospective Study of 525 Patients

Tumor-related factors remain key predictors of NMIBC outcomes, whereas treatment adherence and socioeconomic factors significantly influence recurrence, highlighting the need for an integrated prognostic model.

R. Es-saady, S. Lafdali, Adnane Mortaji et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.